Articles dans des revues avec comité de lecture (43)
  1. 1. Moresi, F., Japón Ruiz, D., Serra, M., Avalos Moreno, M., Garcia, E., Coulonval, K., Pavesi, A., Beck, B., & Bisteau, X. (2026). CDK4/6 inhibition uncovers subtype-specific vulnerabilities and immune-related responses in esophageal squamous cell carcinoma. Cell death & disease. doi:10.1038/s41419-026-08892-x
  2. 2. Descampe, L., Dassy, B., Charara, F., Craciun, L., Verset, L., Pirard, S., Verheye, Q., Leprovost, M., Garcia, M.-I., Vercauteren Drubbel, A., & Beck, B. (2026). Intrinsic mechanisms and microenvironmental cues fine-tune plasticity of esophageal progenitors. Nature communications, 17(1). doi:10.1038/s41467-026-70957-4
  3. 3. Charara, F., Descampe, L., Ruscas-Craciun, L. I., Verset, L., Spinette, A., Ennaji, M., Vander Kuylen, M., Maris, C., Demetter, P., & Beck, B. (2026). Enhanced transcriptomic profiling of esophageal tissue through optimized PAXgene fixation protocols. Genes & Diseases, 13(3), 101842. doi:10.1016/j.gendis.2025.101842
  4. 4. Gillet, N., Bodart, C., & Beck, B. (2025). Pharmacological SHIP2 blockade enhances sensitivity to standard and targeted cancer therapies. Advances in biological regulation, 101130. doi:10.1016/j.jbior.2025.101130
  5. 5. Ramos, A. R., Bregni, G., Gillet, N., Ando, K., Bodart, C., Vercauteren Drubbel, A., Descampe, L., Moresi, F., Bisteau, X., Verheye, Q., Pirard, S., Erneux, C., & Beck, B. (2025). SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma. Molecular cancer.
  6. 6. Vercauteren Drubbel, A., & Beck, B. (2023). Single-cell transcriptomics uncovers the differentiation of a subset of murine esophageal progenitors into taste buds in vivo. Science advances, 9(10), eadd9135. doi:10.1126/sciadv.add9135
  7. 7. Bregni, G., & Beck, B. (2022). Toward Targeted Therapies in Oesophageal Cancers: An Overview. Cancers, 14(6), 1522. doi:10.3390/cancers14061522
  8. 8. Vercauteren Drubbel, A., & Beck, B. (2021). Dedifferentiation of esophageal progenitors in metaplasia and cancer. Molecular and Cellular Oncology. doi:10.1080/23723556.2021.1991758
  9. 9. Vercauteren Drubbel, A., Pirard, S., Kin, S., Dassy, B., Lefort, A., Libert, F., Nomura, S., & Beck, B. (2021). Reactivation of the Hedgehog pathway in esophageal progenitors turns on an embryonic-like program to initiate columnar metaplasia. Cell Stem Cell. doi:10.1016/j.stem.2021.03.019
  10. 10. Redondo Marin, J. A., Bibes, R., Vercauteren Drubbel, A., Dassy, B., Bisteau, X., Maury, E., & Beck, B. (2021). PER2 Circadian Oscillation Sensitizes Esophageal Cancer Cells to Chemotherapy. Biology, 10(4), 266. doi:10.3390/biology10040266
  11. 11. Augereau, A., Mariotti, M., Pousse, M., Filipponi, D., Libert, F., Beck, B., Gorbunova, V., Gilson, E., & Gladyshev, V. V. (2021). Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication under low oxygen. Science advances, 7(8), eabe0174. doi:10.1126/sciadv.abe0174
  12. 12. Ramos, A. R., Ghosh, S., Suhel, T., Chevalier, C., Owusu Obeng, E., Fafilek, B., Krejci, P., Beck, B., & Erneux, C. (2020). Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update. Advances in biological regulation, 75, 100660. doi:10.1016/j.jbior.2019.100660
    13. << Précédent 1 2 3 4 5 6 Suivant >>